search icon
rvlpq-img

RVL Pharmaceuticals plc, Common Stock

RVLPQ

PNK

$1.0E-6

+$0

(0%)

1D
Industry: Biotechnology Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$1.11K
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
0
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
35.47
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$1 L
$0 H
$1.0E-6

About RVL Pharmaceuticals plc, Common Stock

RVL Pharmaceuticals plc operates as a specialty pharmaceutical company. It focuses on the development and commercialization of pharmaceutical products that target markets with underserved patient populations in the ocular and medical aesthetics therapeutic areas in the United States, Argentina, and Hungary. It is commercializing Upneeq (RVL-1201), an oxymetazoline hydrochloride ophthalmic solution, for the treatment of acquired blepharoptosis, or low-lying eyelid in adults. The company was formerly known as Osmotica Pharmaceuticals plc and changed its name to RVL Pharmaceuticals plc in January 2022. RVL Pharmaceuticals plc is headquartered in Bridgewater, New Jersey. more

Industry: BiotechnologySector: Health Care

Returns

Time FrameRVLPQSectorS&P500
1-Week Return--1.67%1.25%
1-Month Return--3.51%1.77%
3-Month Return--4.17%9.07%
6-Month Return--10.65%5.36%
1-Year Return-99%-12.8%19.28%
3-Year Return-100%-2.49%48.86%
5-Year Return-100%21.6%88.54%
10-Year Return-100%72.94%205.26%

Financials

Dec '18Dec '19Dec '20Dec '21Dec '225YR TREND
Total Revenue263.70M240.03M27.76M17.50M49.72M[{"date":"2018-12-31","value":100,"profit":true},{"date":"2019-12-31","value":91.02,"profit":true},{"date":"2020-12-31","value":10.53,"profit":true},{"date":"2021-12-31","value":6.64,"profit":true},{"date":"2022-12-31","value":18.86,"profit":true}]
Cost of Revenue141.96M111.63M3.29M3.62M9.46M[{"date":"2018-12-31","value":100,"profit":true},{"date":"2019-12-31","value":78.64,"profit":true},{"date":"2020-12-31","value":2.32,"profit":true},{"date":"2021-12-31","value":2.55,"profit":true},{"date":"2022-12-31","value":6.66,"profit":true}]
Gross Profit121.75M128.40M24.47M13.88M40.27M[{"date":"2018-12-31","value":94.82,"profit":true},{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":19.06,"profit":true},{"date":"2021-12-31","value":10.81,"profit":true},{"date":"2022-12-31","value":31.36,"profit":true}]
Gross Margin46.17%53.49%88.14%79.33%80.98%[{"date":"2018-12-31","value":52.38,"profit":true},{"date":"2019-12-31","value":60.69,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":90,"profit":true},{"date":"2022-12-31","value":91.88,"profit":true}]
Operating Expenses116.06M125.35M86.21M94.39M99.25M[{"date":"2018-12-31","value":92.59,"profit":true},{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":68.78,"profit":true},{"date":"2021-12-31","value":75.3,"profit":true},{"date":"2022-12-31","value":79.18,"profit":true}]
Operating Income5.68M(280.69M)(90.65M)(82.75M)(58.99M)[{"date":"2018-12-31","value":100,"profit":true},{"date":"2019-12-31","value":-4939.2,"profit":false},{"date":"2020-12-31","value":-1595.14,"profit":false},{"date":"2021-12-31","value":-1456.17,"profit":false},{"date":"2022-12-31","value":-1038.01,"profit":false}]
Total Non-Operating Income/Expense-(35.54M)(8.24M)(3.80M)7.03M[{"date":"2018-12-31","value":"-","profit":true},{"date":"2019-12-31","value":-505.88,"profit":false},{"date":"2020-12-31","value":-117.27,"profit":false},{"date":"2021-12-31","value":-54.06,"profit":false},{"date":"2022-12-31","value":100,"profit":true}]
Pre-Tax Income(118.66M)(298.02M)(94.80M)(82.53M)(51.71M)[{"date":"2018-12-31","value":-11866400000,"profit":false},{"date":"2019-12-31","value":-29802200000,"profit":false},{"date":"2020-12-31","value":-9479500000,"profit":false},{"date":"2021-12-31","value":-8253400000,"profit":false},{"date":"2022-12-31","value":-5171200000,"profit":false}]
Income Taxes(8.98M)(27.12M)(5.78M)315.00K(20.00K)[{"date":"2018-12-31","value":-2851.75,"profit":false},{"date":"2019-12-31","value":-8609.84,"profit":false},{"date":"2020-12-31","value":-1835.56,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-6.35,"profit":false}]
Income After Taxes-(270.90M)(89.01M)(82.85M)(51.69M)[{"date":"2018-12-31","value":"-","profit":true},{"date":"2019-12-31","value":-27090100000,"profit":false},{"date":"2020-12-31","value":-8901300000,"profit":false},{"date":"2021-12-31","value":-8284900000,"profit":false},{"date":"2022-12-31","value":-5169200000,"profit":false}]
Income From Continuous Operations-(270.90M)(89.01M)(82.85M)(51.69M)[{"date":"2018-12-31","value":"-","profit":true},{"date":"2019-12-31","value":-27090100000,"profit":false},{"date":"2020-12-31","value":-8901300000,"profit":false},{"date":"2021-12-31","value":-8284900000,"profit":false},{"date":"2022-12-31","value":-5169200000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2018-12-31","value":"-","profit":true},{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true}]
Net Income(109.68M)(270.90M)(79.59M)(64.92M)(51.69M)[{"date":"2018-12-31","value":-10968100000,"profit":false},{"date":"2019-12-31","value":-27090100000,"profit":false},{"date":"2020-12-31","value":-7958900000,"profit":false},{"date":"2021-12-31","value":-6492000000,"profit":false},{"date":"2022-12-31","value":-5169200000,"profit":false}]
EPS (Diluted)(3.08)(5.14)(1.29)(1.09)(0.56)[{"date":"2018-12-31","value":-308,"profit":false},{"date":"2019-12-31","value":-514,"profit":false},{"date":"2020-12-31","value":-129,"profit":false},{"date":"2021-12-31","value":-109,"profit":false},{"date":"2022-12-31","value":-56,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

RVLPQ
Cash Ratio 0.28
Current Ratio 0.38
Quick Ratio 0.36

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

RVLPQ
ROA (LTM) -23.65%
ROE (LTM) -182.44%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

RVLPQ
Debt Ratio Lower is generally better. Negative is bad. 0.81
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.19

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

RVLPQ
Trailing PE NM
Forward PE NM
P/S (TTM) 0.00
P/B 0.00
Price/FCF NM
EV/R 1.06
EV/Ebitda NM

FAQs

What is RVL Pharmaceuticals plc share price today?

RVL Pharmaceuticals plc (RVLPQ) share price today is $1.0E-6

Can Indians buy RVL Pharmaceuticals plc shares?

Yes, Indians can buy shares of RVL Pharmaceuticals plc (RVLPQ) on Vested. To buy RVL Pharmaceuticals plc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in RVLPQ stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of RVL Pharmaceuticals plc be purchased?

Yes, you can purchase fractional shares of RVL Pharmaceuticals plc (RVLPQ) via the Vested app. You can start investing in RVL Pharmaceuticals plc (RVLPQ) with a minimum investment of $1.

How to invest in RVL Pharmaceuticals plc shares from India?

You can invest in shares of RVL Pharmaceuticals plc (RVLPQ) via Vested in three simple steps:

  • Click on Sign Up or Invest in RVLPQ stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in RVL Pharmaceuticals plc shares
What is RVL Pharmaceuticals plc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of RVL Pharmaceuticals plc (RVLPQ) is 0.00

What is the Market Cap of RVL Pharmaceuticals plc?

The market capitalization of RVL Pharmaceuticals plc (RVLPQ) is $1.11K

What is RVL Pharmaceuticals plc’s stock symbol?

The stock symbol (or ticker) of RVL Pharmaceuticals plc is RVLPQ

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top